RASGenix Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 1

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 3

RASGenix General Information

Description

Operator of an oncology research firm intended to develop technologies for studying RAS (Rat Sarcoma)-dependent diseases in drug discovery. The company offers customizable preclinical studies, genetic manipulation models, and RAS mutation cell line platforms, enabling pharmaceutical, biotech, and academic institutions to evaluate therapies and advance targeted cancer treatments.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • Via Gioacchino Quarello 15/A
  • 10135 Turin
  • Italy
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • Via Gioacchino Quarello 15/A
  • 10135 Turin
  • Italy

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

RASGenix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Accelerator/Incubator 14-May-2024 Completed Generating Revenue
2. Accelerator/Incubator 02-Apr-2024 Completed Generating Revenue
1. Spin-Off 01-Jan-2024 Completed Startup
To view RASGenix’s complete valuation and funding history, request access »

RASGenix Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

RASGenix Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
UniCredit Start Lab Accelerator/Incubator
2i3T Accelerator/Incubator
University of Turin University
To view RASGenix’s complete investors history, request access »

RASGenix FAQs

  • When was RASGenix founded?

    RASGenix was founded in 2024.

  • Where is RASGenix headquartered?

    RASGenix is headquartered in Turin, Italy.

  • What is the size of RASGenix?

    RASGenix has 1 total employees.

  • What industry is RASGenix in?

    RASGenix’s primary industry is Biotechnology.

  • Is RASGenix a private or public company?

    RASGenix is a Private company.

  • What is RASGenix’s current revenue?

    The current revenue for RASGenix is .

  • Who are RASGenix’s investors?

    UniCredit Start Lab, 2i3T, and University of Turin have invested in RASGenix.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process